Fresh Leadership Underscores Organization’s Dedication to Advancing Early-Share Clinical Trials and Accelerating Breakthroughs for Cancer Sufferers Worldwide
CHICAGO, April 13, 2026 /PRNewswire/ — Mr. Richard J Stephenson and Dr. Stacie J. Stephenson, Chairman and Vice-Chair of Gateway for Cancer Research, a nonprofit 501(c)(3) organization dedicated completely to funding innovative early Share I and Share II cancer clinical trials, currently launched a leadership transition marking a up to date chapter in the organization’s growth and impact. Following a nationwide search, Peter J. Steele, frail Government Vice President of the American Cancer Society, has been appointed Chief Government Officer of Gateway for Cancer Research.
When asked why he decided to be a part of Gateway, Steele revealed that his father died of cancer. “Gateway’s mission is deeply inner most to me, and I couldn’t be extra mad to be a part of a team that locations patients on the coronary heart of every decision and dares to impeach, ‘what if?’ – then goes and makes it happen,” he acknowledged.
His appointment shows Gateway’s Board and the Stephensons’ self belief in his skill to lead the organization into its subsequent a part of growth whereas advancing its commitment to patient-centered be taught and scientific innovation.
Founded in 1991, Gateway for Cancer Research used to be built on the thought that promising cancer therapies shouldn’t sit down on the sidelines. This transition ensures continuity in that mission whereas positioning the organization for its subsequent a part of growth. Thus a ways, Gateway has invested better than $126.5 million in early-part be taught, with over $40 million for the time being at work accelerating therapies from the lab to patients of their houses.
Centered completely on early-part clinical trials, an in most cases underfunded nonetheless excessive house, Gateway continues to reinforce clinician-scientists in advancing contemporary therapies and making improvements to patient outcomes extra snappy.
“Gateway has demonstrated what’s feasible when innovation meets action,” acknowledged Richard J Stephenson, Founder of Gateway for Cancer Research. “We’re comfy with the exceptional development made all the plan thru this transition interval and are assured that Peter Steele’s confirmed leadership will extra toughen our skill to fund groundbreaking be taught and shuffle up contemporary and attractive remedy alternate recommendations for patients in want.”
Dr. Stacie J. Stephenson, Vice-Chair of Gateway for Cancer Research, has helped info the organization thru this period, placing forward steadiness and forward momentum all the plan thru its global be taught efforts. Below their leadership, Gateway has expanded its reach, for the time being supporting 58 clinical trials all the plan thru 29 establishments worldwide.
“Gateway for Cancer Research has continuously been pushed by a singular mission: to shuffle up innovative cancer therapies and elevate hope to patients and families all the plan thru the area,” acknowledged Dr. Stephenson. “This transition represents an exhilarating evolution for the organization, as we contain on an actual basis and proceed advancing the intrepid, early-part be taught that has the vitality to replace lives.”
“As I talked about, I’ve considered firsthand what cancer can snatch from a household and at Gateway, we’re now no longer wonderful funding be taught—we’re combating for every patient’s tomorrow. I’m honored to lead an organization that refuses to come to a decision up the reputation quo and is intrepid enough to bid a future where HOPE isn’t wonderful a observe, nonetheless a fact for every person facing cancer,” Steele concluded.
Taking a gaze forward, Gateway stays dedicated to increasing entry to those innovative trials thru decentralized stories and telemedicine, making chopping-edge therapies readily accessible to patients wherever they’re. Presently, Gateway is supporting extra breakthroughs now than ever sooner than.
For extra facts about Gateway for Cancer Research, talk to https://www.gatewaycr.org.
About Gateway for Cancer Research
Gateway for Cancer Research is a nonprofit 501(c)(3) organization dedicated to discovering, funding and furthering innovative cancer be taught that helps cancer patients truly feel better and dwell longer as we work to discontinue cancer as we are aware of it. On legend of beneficiant underwriting, 100% of every donation at as soon as funds Share I and Share II cancer clinical trials at main be taught establishments all the plan thru the area. Since 1991, Gateway has invested better than $126 million to advance better than 255 clinical trials, impacting over 30,000 patients and families.
Media Contact:
Kylie Caputo | (732) 703-1295 | [email protected]
Peep long-established say to download multimedia: https://www.prnewswire.com/info-releases/gateway-for-cancer-be taught-publicizes-leadership-transition-positioning-organization-for-its-subsequent-chapter-of-growth-302740805.html
SOURCE Gateway for Cancer Research
